Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...
This allows us to create more advanced bioprinted heart tissue, with the ability to mature in a laboratory setting, better replicating adult human heart structure. We are excited to build on this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback